Topamax and Topiramate

Topamax, generically known as Topiramate, is a medication prescribed to treat migraines and epilepsy. This drug was manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and is commonly recommended as a remedy for epilepsy.

In March 2011, the Food and Drug Administration (FDA) released a public warning which revealed that the drug rendered infants born to mothers taking the medication 21 times more likely to develop cleft lips or cleft palates. Many women who agreed to take this medication were unaware of the potential risk to their unborn children, as Janssen Pharmaceuticals did not provide adequate warnings.

Several lawsuits are currently pending against Janssen Pharmaceuticals for Topamax birth defect injuries. The first of these was filed in September of 2011 with the Philadelphia Court of Common Pleas, and juries awarded multi-million dollar verdicts to two of the plaintiffs in 2013. More than 100 similar claims remain pending in active litigation.

Birth Defects Linked to Topamax include:

These defects can be severe, and may affect those born with them for their entire lives. The toll of these issues can be emotionally and financially draining, putting strain on families. Pharmaceutical companies have a legal duty to inform the public of potential hazards, and when they neglect this responsibility, they can be held liable for the consequences.

If your child has been born with a defect after the mother took Topamax or Topiramate while pregnant, you could have grounds to file a claim for damages. The attorneys of Blizzard Law PLLC have helped victims across the nation who have faced birth defects caused by a wide range of dangerous drugs, and we can help you hold negligent companies responsible for the damages their medications have caused.